CVRx Announced Availability Of Additional Data Highlighting Long-term Sustained Benefits Of Barostim In Heart Failure Patients With Reduced Ejection Fraction
CVRx Announced Availability Of Additional Data Highlighting Long-term Sustained Benefits Of Barostim In Heart Failure Patients With Reduced Ejection Fraction
CvRx 宣佈提供更多數據,這些數據突顯了 Barostim 對射血分數降低的心力衰竭患者的長期持續益處
CVRx Announced Availability Of Additional Data Highlighting Long-term Sustained Benefits Of Barostim In Heart Failure Patients With Reduced Ejection Fraction
CvRx 宣佈提供更多數據,這些數據突顯了 Barostim 對射血分數降低的心力衰竭患者的長期持續益處
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。